Fresenius Medical Care (FMS) Tops Q3 EPS Views

Fresenius Medical Care (NYSE: FMS) reported Q3 EPS of $1.09, $0.57 better than the analyst estimate of $0.52. Revenue for the quarter came in at $4.6 billion versus the consensus estimate of $4.55 billion.

For earnings history and earnings-related data on Fresenius Medical Care (FMS) click here.

You May Also Be Interested In

• Xerox sells tariff refund claims at a discount to cut debt
• Ferrari CEO says Luce orders "in line with expectations"
• GATX Corp. (GATX) Tops Q2 EPS by 33c ; Offers Guidance